Eugene P. Kennedy's most recent trade in Galera Therapeutics Inc was a trade of 55,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 25, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galera Therapeutics Inc | Eugene P. Kennedy | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2023 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Eugene P. Kennedy | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 31,475 | 31,475 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Eugene P. Kennedy | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 939 | 11,423 (0%) | 0% | 0 | Common Stock |